mRNA therapies to be manufactured in Poland for developers of drugs to treat COVID, potential forms of cancer, and more The Historian automation system enables data integrity and compliance, setting a new benchmark for manufacturing efficiency SyVento Biotech gains advantages in efficiency, research outcomes, and scalability with Cytiva’s end-to-end platform and advanced technologies SyVento Biotech […]

Breakthrough Spatial Biology Solutions Accelerate Immuno-Oncology (IO) Drug Discovery and Development BETHESDA, Md. — Precision for Medicine, a leading next-generation provider of drug development and commercialization services, today announced the integration of Akoya’s PhenoCycler-Fusion 2.0 and early access for the new PhenoCode Discovery IO60 immuno-oncology panel into its service portfolio. Precision for Medicine now offers […]

inCerebro, a pharmaceutical research and development company known for its trailblazing approach to computational drug discovery using quantum mechanics/computing, has officially adopted CDD Vault, an advanced informatics platform from Collaborative Drug Discovery (CDD). This move marks a significant step for inCerebro as it enhances its capabilities in managing, sharing, and analyzing complex research data, from its […]

Domainex is the first CRO to have installed the eProtein Discovery system Installation of Nuclera’s technology expands Domainex’s protein production services Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the […]

Axxam, a leading contract research organisation (CRO) providing integrated early discovery services and solutions across the life sciences industries, is pleased to announce its adoption of CDD Vault, a highly-regarded informatics platform from Collaborative Drug Discovery (CDD). This decision will enhance Axxam’s ability to manage and analyse complex scientific data, supporting its clients’ drug discovery […]

Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors PARIS and PLEASANTON, Calif. — French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics’ Visium HD as part of its pioneering work to understand the unique biology of exceptional cancer survivors, […]

AcouSort has received an order for a six-month rental and application support for an AcouWash system from a leading global pharma company. Initial revenues amount to EUR 14,000. The rental period commenced at the beginning of October and was kicked off with an on-site installation and training at one of the customer’s R&D labs. The […]

Innovative research institute streamlines operations and enhances collaboration with unified laboratory informatics platform Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced that the Ellison Institute of Technology Los Angeles (EIT Los Angeles), a leading interdisciplinary research center focused on cancer and global health, has successfully deployed Sapio Sciences’ Laboratory Information Management System (LIMS) to […]

Consortium includes top universities, hospitals and industry partners, led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust Akoya’s platforms will be used for deep spatial proteomic profiling of thousands of tissue samples from cancer patients to identify biomarkers predicting treatment success MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial […]

Today, Bio-Works Technologies AB has confirmed a significant production-scale order valued at 2.7 million SEK from a prominent Contract Development and Manufacturing Organization (CDMO) based in Sweden. This order represents a strong endorsement of Bio-Works’ advanced chromatographic resins used in the purification of biomolecules. The collaboration with the CDMO further solidifies Bio-Works’ position as a […]